Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
208.3 USD | -0.53% | +1.62% | -16.75% |
08/05 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
07/05 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.75% | 8.12B | |
+73.46% | 12.41B | |
+5.93% | 6.59B | |
+14.69% | 5.46B | |
+42.58% | 5.05B | |
-19.05% | 4.02B | |
-34.55% | 2.47B | |
-2.48% | 2.02B | |
+10.80% | 1.89B | |
+8.04% | 1.74B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01